Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Bhatia Sangeeta N., holds the title of Director at VERTEX PHARMACEUTICALS INC / MA.
On 2026-11-16, the insider transacted 271 shares.The shares were transacted at a weighted average price of $547.86 per share, resulting in a total market-relevant value of $148K.
Bhatia Sangeeta N. (Director) sold $148K of $VRTX
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.